Cargando…
Subcutaneous golimumab induced and maintained clinical response in a child with a biological-experienced steroid-refractory flare of ulcerative colitis: A case report
INTRODUCTION: Golimumab is a fully human antitumor necrosis monoclonal antibody that can be administered by either subcutaneous injection or intravenous infusion. Golimumab is approved for the treatment of the adults with rheumatic diseases, and ulcerative colitis, Whereas in children, golimumab is...
Autores principales: | Alhalabi, Marouf, Eddin, Kamal Alaa, Cheha, Khaled, Abbas, Ahmad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462589/ https://www.ncbi.nlm.nih.gov/pubmed/34559136 http://dx.doi.org/10.1097/MD.0000000000027283 |
Ejemplares similares
-
SARS-CoV-2 (COVID-19) pneumonia patient treated with two doses of infliximab within 2 weeks for acute severe ulcerative colitis: A case report
por: Alhalabi, Marouf, et al.
Publicado: (2022) -
Ustekinumab for steroid-refractory pancolitis in a biologically naive child: A case report and literature review
por: Alhalabi, Marouf
Publicado: (2023) -
Efficacy of two-week therapy with doxycycline-based quadruple regimen versus levofloxacin concomitant regimen for helicobacter pylori infection: a prospective single-center randomized controlled trial
por: Alhalabi, Marouf, et al.
Publicado: (2021) -
Subcutaneous golimumab to treat a biological naïve chronically active ulcerative colitis child. A case report
por: Alhalabi, Marouf M., et al.
Publicado: (2022) -
Mortality and risk factors associated with peptic ulcer bleeding among adult inpatients of Damascus Hospital, Syria: A cross-sectional study
por: Alhalabi, Marouf Mouhammad
Publicado: (2023)